A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years (major virus. Since this part of the HA is relatively conserved among H3 subtype influenza viruses, our peptide vaccine may become the basis for a new strategy to prepare effective vaccines that will overcome the ineffectiveness of classical vaccines attributable to antigenic drift of influenza viruses.

No abstract

Abstract:The selective induction

No abstract